Hemmati, M., Seghatoleslam, A., Rasti, M., Ebadat, S., Mosavari, N., Habibagahi, M., … Mostafavi-Pour, Z. (2011). Expression and Purification of Recombinant Mycobacterium Tuberculosis (TB) Antigens, ESAT-6, CFP-10 and ESAT- 6/CFP-10 and Their Diagnosis Potential for Detection of TB Patients. Iranian Red Crescent Medical Journal, 13(8), 556-63. (Original work published 2011)
tuberculosis
Boer, M. (2013). CD39 is involved in mediating suppression by Mycobacterium bovis BCG-activated human CD8(+) CD39(+) regulatory T cells. European Journal of Immunology, 43(7), 1925-32. https://doi.org/10.1002/eji.201243286 (Original work published 2013)
Li, G., Liu, G., Song, N., Kong, C., Huang, Q., Su, H., … Wang, H. (2015). A novel recombinant BCG-expressing pro-apoptotic protein BAX enhances Th1 protective immune responses in mice. Molecular Immunology, 66(2), 346-56. https://doi.org/10.1016/j.molimm.2015.04.003 (Original work published 2015)
Yang, E., Wang, F., Xu, Y., Wang, H., Hu, Y., Shen, H., & Chen, Z. (2015). A lentiviral vector-based therapeutic vaccine encoding Ag85B-Rv3425 potently increases resistance to acute tuberculosis infection in mice. Acta Biochimica et Biophysica Sinica, 47(8), 588-96. https://doi.org/10.1093/abbs/gmv059 (Original work published 2015)
Boer, M., van Meijgaarden, K., Goletti, D., Vanini, V., Prins, C., Ottenhoff, T., & Joosten, S. (2016). KLRG1 and PD-1 expression are increased on T-cells following tuberculosis-treatment and identify cells with different proliferative capacities in BCG-vaccinated adults. Tuberculosis (Edinburgh, Scotland), 97, 163-71. https://doi.org/10.1016/j.tube.2015.11.008 (Original work published 2016)
Hussein, J., Zewdie, M., Yamuah, L., Bedru, A., Abebe, M., Dagnew, A., … Aseffa, A. (2018). A phase I, open-label trial on the safety and immunogenicity of the adjuvanted tuberculosis subunit vaccine H1/IC31® in people living in a TB-endemic area. Trials, 19(1), 24. https://doi.org/10.1186/s13063-017-2354-0 (Original work published 2018)
Huang, H., Wang, F., Yang, E., Wang, H., Gao, P., & Shen, H. (2018). Assessment of recombinant plasmid expressing fusion antigen Ag85B-Rv3425 in management of acute tuberculosis infection in mice. Experimental and Therapeutic Medicine, 15(3), 3034-3039. https://doi.org/10.3892/etm.2018.5785 (Original work published 2018)
Younis, S., Barnier-Quer, C., Heuking, S., Sommandas, V., Brunner, L., Werff, N., … Remarque, E. (2018). Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation. BMC Immunology, 19(1), 6. https://doi.org/10.1186/s12865-018-0245-0 (Original work published 2018)
Dijkman, K., Vervenne, R., Sombroek, C., Boot, C., Hofman, S., van Meijgaarden, K., … Verreck, F. (2019). Disparate Tuberculosis Disease Development in Macaque Species Is Associated With Innate Immunity. Frontiers in Immunology, 10, 2479. https://doi.org/10.3389/fimmu.2019.02479 (Original work published 2019)
Okeke, C., Amilo, G., Ifeanyichukwu, M., & Okeke, C. (2020). Comparison of the levels of some hemostatic and inflammatory markers between tuberculosis patients with and without malaria at pretreatment, intensive, and continuation phase treatment. International Journal of Mycobacteriology, 9(4), 373-379. https://doi.org/10.4103/ijmy.ijmy_174_20 (Original work published 2020)